People

Hariprasad  Gali , PhD

Assistant Professor of Research

Department of Pharmaceutical Sciences

405-271-6593  x47877
405-271-7505
CPB 301
hariprasad-gali@ouhsc.edu
Phone
Fax
Office
Email

Research Summary

Research focused on the development of new Positron Emission Tomography (PET) agents for imaging cancer and other diseases.

Education & Experience

Education
  • Ph.D. (Chemistry). University of Missouri, 1999.
  • MSc. (Chemistry). University of Hyderabad, India. 1995.
  • B.Sc. (Math, Physics, Chemistry).Osmania University, India. 1993.

Professional Experience:

  • Assistant Professor of Research, Dept. of Pharmaceuticals Sciences College of Pharmacy OUHSC, OKC, OK. 2008 to present.
  • Research Scientist. Lynntech, Inc. College Station, TX. 2002-2007.
  • Postdoctoral Fellow. Dept. of Radiology, School of Medicine, University of Missouri, Columbia, MO. 1999-2002.
  • Graduate Research Assistant. Dept. of Radiology, University of Missouri, Columbia, MO. 1996-1999.

Honors & Service

Honors
  • Biography listed in Marquis Who's Who in Medicine and Healthcare (5th Ed.), 2004-2005; (6th Ed.), 2006-2007; Who's Who in Science and Technology (8th Ed.), 2005-2006; (9th Ed.), 2006-2007; Who's Who in America (60th Diamond Ed.), 2006; (61st Ed.), 2007; Who's Who in Emerging Leaders (1st Ed.), 2007.
  • Summer Research Fellowship awarded by the Jawaharlal Nehru Center for Advanced Scientific Research, Bangalore, India, 1994 and 1995.
  • Junior Research Fellowship awarded by the Council of Scientific and Industrial Research, India (1994) and the University Grants Commission, India (1995) on the basis of a national level scholastic aptitude test.

Service

  • Member, Society of Nuclear Medicine, 2003-present.
  • Member, American Chemical Society, 1997-present.

Selected Publications & Presentations

  • Mroz P, Pawlak A, Satti M, Lee H, Wharton T, Gali H, Sarna T, Hamblin MR. "Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism." Free Radical Biol Med 2007, 43:711-719.
  • Giblin MF, Gali H, Sieckman GL, Owen NK, Hoffman TJ, Volkert WA, Forte LR. "In vitro and in vivo evaluation of [111]In-Labeled E. Coli heat-stable enterotoxin analogs for specific targeting of human breast cancers." Breast Cancer Res Treat 2006; 98:7-15.
  • Tegos GP, Demidova TN, Arcila-Lopez D, Lee H, Wharton T, Gali H, Hamblin MR. "Cationic fullerenes are effective and selective antimicrobial photosensitizers." Chem Biol 2005; 12:1127-1135.
  • Giblin MF, Gali H, Sieckman GL, Owen NK, Hoffman TJ, Forte LR, Wolkert WA. "In vitro and in vivo comparison of human escherichia coli heat-stable peptide analogues incorporating the [111]in-DOTA group and distinct linker moieties." Bioconjugate Chem 2004; 15:872-880.
  • Hoffman TJ, Gali H, Smith CJ, Sieckman GL, Hayes DL, Owen NK, Volkert WA. "Novel series of [111]In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells." J Nucl Med 2003; 44:823-831.
show more
 

Current Grants Awarded

  • Presbyterian Health Foundation (PHF) - Development of F-18 labeled human islet deposits by PET